Survey of treatment practices for immunocompromised patients with COVID-19 in Australasia
- Author(s)
- Moso, MA; Sasadeusz, J; Morrissey, CO; Bond, K; Guy, S; Slavin, MA; Dendle, C;
- Details
- Publication Year 2023-04,Volume 53,Issue #4,Page 619-624
- Journal Title
- Internal Medicine Journal
- Publication Type
- Research article
- Abstract
- Coronavirus disease 2019 (COVID-19) in immunocompromised patients can lead to severe and prolonged illness. Data are limited with regard to management of COVID-19 in this setting, particularly in persistent or recrudescent infection. The authors conducted an online survey among infectious diseases doctors to determine current approaches to treatment across Australasia. There was marked variability in responses relating to the diagnostic modalities and use of antiviral agents in patients with immunocompromise, highlighting the need for high-quality studies to guide treatment decisions in this group.
- Publisher
- Wiley
- Keywords
- Humans; *covid-19; Antiviral Agents/therapeutic use; Immunocompromised Host; Surveys and Questionnaires; Australasia/epidemiology; Covid-19; antivirals; immunocompromised; malignancy; survey; transplant
- Department(s)
- Infectious Diseases
- PubMed ID
- 36929677
- Publisher's Version
- https://doi.org/10.1111/imj.16064
- Open Access at Publisher's Site
https://doi.org/10.1111/imj.16064- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2023-08-03 07:58:25
Last Modified: 2023-08-03 08:01:33